Publications by authors named "Peter Bujdak"

Claim this Profile
B
Biochemical Recurrence in High-Risk Localized Prostate Cancer: A Comparison of Laparoscopic Prostatectomy and External Radiotherapy.
Lubos Rybar, Patrik Hesko, Michal Miko, Peter Bujdak, Stefan Harsanyi

Medicina (Kaunas)· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Screening for the Key Proteins Associated with Rete Testis Invasion in Clinical Stage I Seminoma via Label-Free Quantitative Mass Spectrometry.
Lucia Borszéková Pulzová, Jan Roška, Michal Kalman, Ján Kliment, Pavol Slávik

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Relation between testosterone levels and body composition, physical functioning and selected biochemical parameters in adult males].
Milan Sedliak, Michal Kralik, Jan Cvecka, Gabriel Buzgo, Matus Putala, Peter Bujdak

Vnitr Lek· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced Reconstruction of Vesicourethral Support (ARVUS) during robot-assisted radical prostatectomy: first independent evaluation and review of other factors influencing 1 year continence outcomes.
Viktor Kováčik, Matúš Maciak, Vladimír Baláž, Jozef Babeľa, Viliam Kubas

World J Urol· August 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Expression of E-cadherin, Ki-67, and p53 in urinary bladder cancer in relation to progression, survival, and recurrence.
Stanislav Ziaran, Stefan Harsanyi, Katarina Bevizova, Zuzana Varchulova Novakova, Branislav Trebaticky, Peter Bujdak

Eur J Histochem· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Strength training as a supplemental therapy for androgen deficiency of the aging male (ADAM): study protocol for a three-arm clinical trial.
Michal Kralik, Jan Cvecka, Gabriel Buzgo, Matus Putala, Barbara Ukropcova, Peter Bujdak

BMJ Open· September 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient's and physician's behavior on the management of benign prostatic hyperplasia among the patients at the risk of clinical progression. A multicenter noninterventional trial in Slovakia by "Prostate and Expectations of Treatment: Epidemiology Research" (PETER) study group.
Peter Weibl, Peter Laurinc, Roman Tomaškin, Tobias Klatte, Shahrokh Shariat F

Wien Klin Wochenschr· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient's behavior and attitudes toward the management of benign prostatic hyperplasia among patients with the risk of disease progression: prospective study by "Prostate and Expectations of Treatment Epidemiology Research (PETER) study group".
Peter Weibl, Tobias Klatte, Peter Laurinc, Roman Tomaškin, Shahrokh F Shariat

Wien Klin Wochenschr· May 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The relationship between renal cell carcinoma and nuclear retinoid/rexinoid receptors.
Vladimir Lenko, Lucia Bialesova, Dana Macejova, Peter Bujdak, Jan Breza

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub· December 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Carbonic anhydrase IX is a clinically significant tissue and serum biomarker associated with renal cell carcinoma.
Martina Takacova, Maria Bartosova, Lucia Skvarkova, Miriam Zatovicova, Ivana Vidlickova, Peter Bujdak

Oncol Lett· January 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis